Sernova Corp. is a clinical stage regenerative medicine company developing cell therapy based medical technologies for the treatment of chronic debilitating diseases such as diabetes, blood disorders including hemophilia and other diseases all of which are treated through replacement of proteins or hormones missing or in short supply within the body. Sernova is developing the Cell Pouch TM , a scalable, implantable medical device which forms a vascularized organ like environment for the transplantation of its locally immune protected therapeutic cells self cells, donor cells, ethically sourced stem cell derived therapeutic cells or xenogeneic cells which then release proteins and/or hormones as required by the body. The objective of the company s products is to disrupt the standard of care treatments for these serious diseases to improve efficacy, significantly improve patient quality of life and to decrease the severe debilitating disease effects that progress with the standard of care treatments. The product to treat diabetes involves implantation of a small biocompatible medical device under the skin into which are placed immune protected cells which connect to the blood vessel supply to read blood sugar levels and release insulin accordingly, replacing the metabolic function of the pancreas. For hemophelia the cells would release the required protein, Factor VIII on a constant basis reducing or eliminating the need for frequent infusions of Factor VIII.
Quote | Sernova Corp (OTCMKTS:SEOVF)
Last: | $0.3295 |
---|---|
Change Percent: | -2.65% |
Open: | $0.3371 |
Close: | $0.3295 |
High: | $0.34 |
Low: | $0.3295 |
Volume: | 29,167 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
News | Sernova Corp (OTCMKTS:SEOVF)
(TheNewswire) Type 1 diabetes (T1D) Cohort 2 patient data demonstrates favorable islet engraftment and long-term survival of human donor islets in the Cell Pouch First treated Cohort 1 patient in the T1D clinical trial to celebrate four years of insulin independence and ...
2024-03-27 17:08:02 ET © 2020 www.B-TV.com . All Rights Reserved. Regenerative medicine solution that could be used for diabetes and other chronic diseases Sernova is a regenerative medicine therapeutics company. They are developing therapeutics platform technologies ...
Message Board Posts | Sernova Corp (OTCMKTS:SEOVF)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $SEOVF News Article - Sernova Announces Research Collaboration with AstraZeneca to Eval | whytestocks | investorshangout | 05/03/2023 6:45:49 PM |
Not sure what impact this will have: | KeepOn | investorshub | 04/15/2023 2:35:24 AM |
whytestocks: $SEOVF News Article - Sernova Announces Advancements with its Novel Cell Pouch System(T | whytestocks | investorshangout | 01/30/2023 4:45:44 PM |
Me 2 | Dr Martin VanNostrand | investorshub | 01/10/2023 12:22:26 PM |
whytestocks: $SEOVF News Article - The Principal Investigator in Sernova's Type 1 Diabetes (T1D) Tri | whytestocks | investorshangout | 01/10/2022 1:10:50 PM |
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) Type 1 diabetes (T1D) Cohort 2 patient data demonstrates favorable islet engraftment and long-term survival of human donor islets in the Cell Pouch First treated Cohort 1 patient in the T1D clinical trial to celebrate four years of insulin independence and ...
2024-03-27 17:08:02 ET © 2020 www.B-TV.com . All Rights Reserved. Regenerative medicine solution that could be used for diabetes and other chronic diseases Sernova is a regenerative medicine therapeutics company. They are developing therapeutics platform technologies ...
2024-03-27 17:08:02 ET A new approach to treating chronic diseases Sernova is a regenerative medicine therapeutics company. They're developing therapeutics platform technologies to treat chronic diseases through a regenerative medicine approach. The company's primary focus is the ...